RT Journal Article
SR Electronic
T1 Relationship among work–treatment balance, job stress, and work engagement in Japan: A cross-sectional study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.23.21265407
DO 10.1101/2021.10.23.21265407
A1 Ikegami, Kazunori
A1 Ando, Hajime
A1 Eguchi, Hisashi
A1 Tsuji, Mayumi
A1 Tateishi, Seiichiro
A1 Mori, Koji
A1 Muramatsu, Keiji
A1 Fujino, Yoshihisa
A1 Ogami, Akira
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/10/26/2021.10.23.21265407.abstract
AB There is a drive to support workers undergoing medical treatment who wish to continue working in Japan, known as the work–treatment balance. It is hoped that this support for the work–treatment balance could boost their mental health. This study examines the relationship among the work–treatment balance, job stress, and work engagement. This study was conducted in December 2020 in Japan, with 27,036 participants. We divided the participants into three groups by the receipt state of support for the work–treatment balance: control group (no need the support), unsupported group, and supported group. The scores of the parameters of the job content questionnaire and the Utrecht Work Engagement Scale (UWES-3) were compared among groups using a multilevel regression with age-sex or multivariate-adjusted models. In the two models, the job control score of the unsupported group was significantly lower than that of the control group. The two social support scores of the supported group were significantly higher than those of the control group. The scores of the UWES-3 of the unsupported group were significantly lower than those of the control group. The support of work–treatment balance for workers could have a positive impact on their mental health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported and partly funded by a research grant from the University of Occupational and Environmental Health, Japan (no grant number); Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004), Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), and Hitachi Systems, Ltd. (no grant number), and scholarship donations from Chugai Pharmaceutical Co., Ltd. (no grant number).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of the University of Occupational and Environmental Health, Japan gave ethical approval (reference No. R2-079) for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the nature of this research, the participants of this study did not consent to their data being publicly shared; hence, supporting data will not be made available.